Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
Status:
Terminated
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of ixabepilone plus capecitabine or
docetaxel plus capecitabine on shrinking or slowing the growth of metastatic breast cancer in
women. The safety of this combination therapy will also be evaluated.